i-SENS Inc Cash Flow Conversion Efficiency
i-SENS Inc cash flow conversion efficiency. Based on the latest financial reports, i-SENS Inc (099190) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.56 Billion ≈ $-1.06 Million USD) by net assets (₩356.49 Billion ≈ $241.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of i-SENS Inc (2012–2025)
Cash flow conversion efficiency of i-SENS Inc from 2012 to 2025. This chart illustrates how i-SENS Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of i-SENS Inc for real-time trading data and today's change.
i-SENS Inc Cash Flow Conversion Ratio Explained
i-SENS Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
i-SENS Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of i-SENS Inc ranked by their cash flow conversion efficiency. Also see 099190 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BayWa AG vNa
XETRA:BYW6
|
0.166x |
|
Compugen
TA:CGEN
|
0.049x |
|
Saniona AB
ST:SANION
|
-0.125x |
|
Daeho Al Co. Ltd.
KO:069460
|
0.081x |
|
Emilia Devel
TA:EMDV
|
0.066x |
|
Sea Harvest Group Ltd
JSE:SHG
|
0.228x |
|
Central Hydropower JSC
VN:CHP
|
0.084x |
|
Cymechs Inc
KQ:160980
|
0.045x |
Annual Cash Flow Conversion Efficiency for i-SENS Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of i-SENS Inc from 2012 to 2025. Review cash generation quality of i-SENS Inc to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩338.32 Billion ≈ $229.28 Million |
₩20.12 Billion ≈ $13.63 Million |
0.059x | -11.16% |
| 2024-12-31 | ₩342.98 Billion ≈ $232.43 Million |
₩22.96 Billion ≈ $15.56 Million |
0.067x | +55.73% |
| 2023-12-31 | ₩303.49 Billion ≈ $205.67 Million |
₩13.05 Billion ≈ $8.84 Million |
0.043x | +84.64% |
| 2022-12-31 | ₩285.81 Billion ≈ $193.69 Million |
₩6.65 Billion ≈ $4.51 Million |
0.023x | -63.73% |
| 2021-12-31 | ₩268.33 Billion ≈ $181.84 Million |
₩17.22 Billion ≈ $11.67 Million |
0.064x | -59.30% |
| 2020-12-31 | ₩219.49 Billion ≈ $148.75 Million |
₩34.61 Billion ≈ $23.46 Million |
0.158x | -17.49% |
| 2019-12-31 | ₩198.56 Billion ≈ $134.56 Million |
₩37.95 Billion ≈ $25.72 Million |
0.191x | +76.94% |
| 2018-12-31 | ₩180.93 Billion ≈ $122.61 Million |
₩19.54 Billion ≈ $13.24 Million |
0.108x | -21.41% |
| 2017-12-31 | ₩162.80 Billion ≈ $110.32 Million |
₩22.38 Billion ≈ $15.16 Million |
0.137x | +75.44% |
| 2016-12-31 | ₩149.67 Billion ≈ $101.43 Million |
₩11.73 Billion ≈ $7.95 Million |
0.078x | -54.15% |
| 2015-12-31 | ₩132.02 Billion ≈ $89.47 Million |
₩22.56 Billion ≈ $15.29 Million |
0.171x | +13.76% |
| 2014-12-31 | ₩118.81 Billion ≈ $80.51 Million |
₩17.85 Billion ≈ $12.09 Million |
0.150x | -3.22% |
| 2013-12-31 | ₩104.32 Billion ≈ $70.70 Million |
₩16.19 Billion ≈ $10.97 Million |
0.155x | +108.16% |
| 2012-12-31 | ₩68.44 Billion ≈ $46.38 Million |
₩5.10 Billion ≈ $3.46 Million |
0.075x | -- |
About i-SENS Inc
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more